Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Timmermann

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Psychopharmacology (Oxford, England)|February 11, 2021
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settingsCarla Pallavicini, Federico Cavanna, Federico Zamberlan, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 1, 2023
Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor ExpressionStefano Delli Pizzi, Piero Chiacchiaretta, Carlo Sestieri, et al.
Frontiers in Pharmacology|November 20, 2018
Predicting Responses to Psychedelics: A Prospective StudyEline C H M Haijen, Mendel Kaelen, Leor Roseman, et al.
Network Neuroscience (Cambridge, Mass.)|May 27, 2024
Effects of classic psychedelic drugs on turbulent signatures in brain dynamicsJosephine Cruzat, Yonatan Sanz Perl, Anira Escrichs, et al.
Journal of Psychopharmacology (Oxford, England)|November 14, 2022
Body mass index (BMI) does not predict responses to psilocybinMeg J Spriggs, Bruna Giribaldi, Taylor Lyons, et al.
Frontiers in Psychiatry|January 26, 2024
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trialEllen James, David Erritzoe, Tiffanie Benway, et al.
Brain : a Journal of Neurology|September 13, 2023
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortexAndrea I Luppi, Manesh Girn, Fernando E Rosas, et al.
Neuroimage|October 20, 2023
LSD-induced changes in the functional connectivity of distinct thalamic nucleiStefano Delli Pizzi, Piero Chiacchiaretta, Carlo Sestieri, et al.
Journal of Psychopharmacology (Oxford, England)|October 28, 2023
Psychological and physiological effects of extended DMTLisa X Luan, Emma Eckernäs, Michael Ashton, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Psychopharmacology (Oxford, England)|February 11, 2021
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settingsCarla Pallavicini, Federico Cavanna, Federico Zamberlan, et al.
Eclinicalmedicine|January 7, 2025
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialDavid Erritzoe, Tommaso Barba, Kyle T Greenway, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 1, 2023
Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor ExpressionStefano Delli Pizzi, Piero Chiacchiaretta, Carlo Sestieri, et al.
Frontiers in Pharmacology|November 20, 2018
Predicting Responses to Psychedelics: A Prospective StudyEline C H M Haijen, Mendel Kaelen, Leor Roseman, et al.
Network Neuroscience (Cambridge, Mass.)|May 27, 2024
Effects of classic psychedelic drugs on turbulent signatures in brain dynamicsJosephine Cruzat, Yonatan Sanz Perl, Anira Escrichs, et al.
Journal of Psychopharmacology (Oxford, England)|November 14, 2022
Body mass index (BMI) does not predict responses to psilocybinMeg J Spriggs, Bruna Giribaldi, Taylor Lyons, et al.
Frontiers in Psychiatry|January 26, 2024
Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trialEllen James, David Erritzoe, Tiffanie Benway, et al.
Brain : a Journal of Neurology|September 13, 2023
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortexAndrea I Luppi, Manesh Girn, Fernando E Rosas, et al.
Neuroimage|October 20, 2023
LSD-induced changes in the functional connectivity of distinct thalamic nucleiStefano Delli Pizzi, Piero Chiacchiaretta, Carlo Sestieri, et al.
Journal of Psychopharmacology (Oxford, England)|October 28, 2023
Psychological and physiological effects of extended DMTLisa X Luan, Emma Eckernäs, Michael Ashton, et al.
Pageof 7